<div id="content" class="col-md-12" style="">
<div data-drupal-messages-fallback="" class="hidden"/><div id="block-medsites-page-title" class="widget block">
<h1><span property="schema:name">Cirrhosis</span>
</h1>
</div>
<div id="block-medsites-content" class="widget block">
<article data-history-node-id="940" role="article" about="/commodorecompendium/cirrhosis" typeof="schema:WebPage">
<div>
<div property="schema:text" class="field field--name-body field--type-text-with-summary field--label-hidden field__item"><div class="WordSection1">
<table class="TableGrid8" style="width:100.0%; border-collapse:collapse; border:none" width="100%">
<tbody>
<tr>
<td style="border-bottom:1px solid black; width:100%; padding:0in 7px 0in 0in; height:12px; border-top:2px double black; border-right:none; border-left:none">
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino">Cirrhosis Overview – Lee Richardson</span></span></b></span></span></span></span></p>
</td>
</tr>
</tbody>
</table>
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Background</span></span></span></span></span></span></p>
<ul>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">For any patient admitted with cirrhosis, know the etiology of their cirrhosis, whether they are compensated or decompensated, and their admission MELD score.</span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Etiology:</span></span></span></span></span></span>
<ul>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Most common causes = Alcohol-associated liver disease, non-alcoholic steatohepatitis (NASH) and HCV (becoming less common with DAA success)</span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Less common causes: HBV, metabolic (hemochromatosis, Wilson’s disease), A1AT deficiency, autoimmune hepatitis, PSC, PBC, veno-occlusive disease, R sided heart disease (congestive hepatopathy), and medication-induced</span></span></span></span></span></span></li>
</ul>
</li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Decompensated Cirrhosis:  Cirrhosis + Ascites, Hepatic Encephalopathy or Gastroesophageal Variceal Hemorrhage (the presence of varices without prior hemorrhage is not decompensation)</span></span></span></span></span></span>
<ul>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Average life expectancy of a patient with compensated cirrhosis = 10-13 years</span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Average life expectancy of a patient with decompensated cirrhosis = 2 years </span></span></span></span></span></span></li>
</ul>
</li>
</ul>
</div>
<p> </p>
<div class="WordSection2">
<p> </p>
<p><span style="page:WordSection2"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Evaluation</span></span></span></span></span></span></p>
<ul>
<li><span style="page:WordSection2"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Goal is to establish the diagnosis of cirrhosis, determine the cause of cirrhosis and determine candidacy and necessary evaluation for transplantation.</span></span></span></span></span></span></li>
<li><span style="page:WordSection2"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">History: </span></span></span></span></span></span>
<ul>
<li><span style="page:WordSection2"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Known history of prior liver disease (if so, from what, and when did they learn about it?). Presence/absence of: fatigue, easy bruising, lower extremity edema, weight loss, pruritus, yellowing of the skin or eyes, increasing abdominal girth, prior episodes of disorientation to place, person, or time, sleep disturbances.</span></span></span></span></span></span></li>
<li><span style="page:WordSection2"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Extensive social hx including alcohol (start year, quitting year, avg amt/day, prior treatment, DUI) and drug use hx (type and route plus the above elements in EtOH hx), family history of liver disease</span></span></span></span></span></span></li>
</ul>
</li>
<li><span style="page:WordSection2"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Physical exam: Splenomegaly, caput medusae, ascites, asterixis/HE, conjunctival icterus, spider angiomata, gynecomastia, palmar erythema, jaundice, testicular atrophy, easy bruising/bleeding, edema/anasarca</span></span></span></span></span></span></li>
<li><span style="page:WordSection2"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Labs:</span></span></span></span></span></span>
<ul>
<li><span style="page:WordSection2"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Initial Workup: CMP, CBC, U/A, HCV antibody, HBV panel, iron panel (ferritin, transferrin saturation), AFP, Peth</span></span></span></span></span></span></li>
<li><span style="page:WordSection2"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Unless requested by the hepatology team, the following tests can be deferred to the OP setting: AMA (PBC), ASMA (AIH), ANA w/ reflex, IgG, A1AT phenotype, ceruloplasmin (wilson’s), generally defer anti-LKM, anti-SLA (type 2 AIH, requires attending approval) to Hep recs</span></span></span></span></span></span></li>
</ul>
</li>
<li><span style="page:WordSection2"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Imaging: </span></span></span></span></span></span>
<ul>
<li><span style="page:WordSection2"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Abdominal u/s with duplex unless done in past 6 months, or indication for repeating (e.g., concern for PVT w/ new EVH)</span></span></span></span></span></span></li>
<li><span style="page:WordSection2"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">consider triple phase CTAP (contrasted study that looks at arterial and venous phases) vs MRI abdomen w/contrast if required by hep team (transplant eval)</span></span></span></span></span></span></li>
<li><span style="page:WordSection2"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">HCC surveillance is further discussed below</span></span></span></span></span></span></li>
</ul>
</li>
<li><span style="page:WordSection2"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Liver biopsy: Gold standard for diagnosis not always needed if clinical picture, labs, and imaging consistent with cirrhosis (See Radiology Section for who to consult for biopsy)</span></span></span></span></span></span></li>
</ul>
</div>
<p> </p>
<p><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Management</span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Malnutrition occurs in 20-60% of patients with cirrhosis</span></span></span></span></span>
<ul style="list-style-type:circle">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Nutrition consult if ascites present (unless recently done)</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">High protein (1.2-1.5g/kg) diet</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">2g Na restriction, reinforce regularly</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Consider MVI, folate, thiamine, particularly to pts w/ EtOH Use Disorder</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Fluid restriction only needed for hyponatremia (as noted below)</span></span></span></span></span></li>
</ul>
</li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Ensure pts are up to date on required vaccines; these can be administered while inpatient before discharge. Indicated vaccines include HBV/HAV, PPSV23, Prevnar, Flu, COVID 19 </span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Consider addiction psych (medical therapy) and SW c/s (behavioral therapy with IOP, AA) for EtOH use disorder</span></span></span></span></span></li>
</ul>
<p> </p>
<p><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Additional Information</span></span></span></span></span></p>
<p><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Lab abnormalities in cirrhosis:</span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Calculate daily MELD-Na scores in pts being considered for Liver transplant</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Coagulopathies: thrombocytopenia (from both hypersplenism and increased PLT sequestration and </span></span><span style="font-size:12.0pt"><span style="font-family:&quot;Times New Roman&quot;,serif">↓ </span></span><span style="font-size:12.0pt"><span style="font-family:Palatino">thrombopoietin production in liver), </span></span><span style="font-size:12.0pt"><span style="font-family:&quot;Times New Roman&quot;,serif">↓</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> coagulation factor production </span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Hyponatremia: Usually hypervolemic hyponatremia in cirrhotic patients; benefit from fluid restriction if hyponatremic</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Hypoalbuminemia: Albumin transfusion is indicated in certain scenarios (detailed below) for volume expansion, anti-inflammatory and anti-oxidant properties</span></span></span></span></span>
<ul style="list-style-type:circle">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Order 25% albumin and NOT 5% (5% albumin is only used to maintain effective circulating volume following major hepatic resection or hepatic transplant)</span></span></span></span></span></li>
</ul>
</li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Indications for albumin administration:</span></span></span></span></span>
<ul style="list-style-type:circle">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">SBP (see SBP section)</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">LVP (see Ascites section)</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Diagnosis/Treatment  of HRS (see HRS section)</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Hyponatremia (&lt;125 and not responsive to fluid restriction)</span></span></span></span></span></li>
</ul>
</li>
</ul>
</div>
</div>
</article>
</div>
</div>